Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics

Country

Status

More filters

Keywords

City

Remote participation

27277studies shown

Showing 6,817-6,828 of 27,277

CompletedEUCTR 2005-004167-27

A Phase 3, randomized, 6-month, double blind trial in subjects with Bipolarity type I to evaluate the continued safety and maintenance of effect of Ziprasidone plus a mood stabilizer (vs placebo p...

Official study title

A Phase 3, randomized, 6-month, double blind trial in subjects with Bipolar I Disorder to evaluate the continued safety and maintenance of effect of Ziprasidone plus a mood stabilizer (vs placebo p...

Original registry wording; source language not specified.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Germany

BipolarityHistorical research record

Countries: Germany, Italy, Spain, + 1 other
Sponsor: Pfizer, S.A.

View study

TerminatedEUCTR 2008-000763-42

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, 10-WEEK PLACEBO CONTROLLED FIXED DOSE STUDY OF PD 0332334 AND PAROXETINE EVALUATING THE EFFICACY AND SAFETY OF PD 0332334 FOR THE TREATMENT OF G...

This study ended early.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Hungary

AnxietyHistorical research record

Countries: Hungary
Sponsor: Pfizer Inc., 235 East 42nd Street, New York, NY 10017

View study

TerminatedEUCTR 2008-000762-23

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, 10-WEEK, PLACEBO CONTROLLED FIXED DOSE STUDY OF PD 0332334 AND PAROXETINE EVALUATING THE EFFICACY AND SAFETY OF PD 0332334 FOR THE TREATMENT ...

This study ended early.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Germany

AnxietyHistorical research record

Countries: Germany, Hungary, Italy
Sponsor: PFIZER

View study

TerminatedEUCTR 2019-002640-25

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF SAGE-217 WITH FIXED, REPEATED TREATMENT REGIMEN ON RELAPSE PREVENTION IN ADULTS WITH MAJOR DEPRESSIVE DIS...

This study ended early.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Denmark

DepressionHistorical research record

Countries: United Kingdom, Denmark, Spain
Sponsor: Sage Therapeutics, Inc.

View study

CompletedEUCTR 2016-003437-18

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (Enhance-2)

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Germany

SchizophreniaHistorical research record

Countries: Germany
Sponsor: ACADIA Pharmaceuticals Inc.

View study

CompletedEUCTR 2018-002749-12

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of ITI-007 Adjunctive to Lithium or Valproate in the Treatment of Patients with Major D...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria

Bipolarity, DepressionHistorical research record

Countries: Bulgaria
Sponsor: Intra-Cellular Therapies, Inc. (ITI)

View study

CompletedEUCTR 2019-004440-29

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Efficacy and Safety of Lumateperone Monotherapy in the Treatment of Patients with Major Depressive Episodes...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria

Depression, BipolarityHistorical research record

Countries: Bulgaria
Sponsor: Intra-Cellular Therapies, Inc. (ITI)

View study

CompletedEUCTR 2016-000756-98

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating the Efficacy, Safety and Tolerability of Cariprazine in Patients with Bipo...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria

Bipolarity, DepressionHistorical research record

Countries: Bulgaria, Croatia, Slovakia
Sponsor: Forest Laboratories LLC, an Allergan Affiliate

View study

TerminatedEUCTR 2004-003927-11

A Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial Evaluating the Safety and Efficacy of Asenapine in Subjects Continuing Lithium or ValproicAcid/Divalproex Sodium for the Treatment of...

This study ended early.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Czech Republic

BipolarityHistorical research record

Countries: Czechia
Sponsor: NV Organon

View study

CompletedEUCTR 2011-002292-41

A Phase 3, Short-Term, Multicenter, Placebo-Controlled, Randomized Withdrawal Study of LY2140023 Monohydrate in Patients with DSM-IV-TR Schizophrenia

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Greece

SchizophreniaHistorical research record

Countries: Greece
Sponsor: Eli Lilly and Company

View study

CompletedEUCTR 2009-011745-94

A Phase 3b, Double-blind, Randomised, Active-controlled, Parallel-group Study to Compare the Time to Response of Lisdexamfetamine Dimesylate to Atomoxetine Hydrochloride in Children and Adolescents...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Belgium

ADHDHistorical research record

Countries: France, United Kingdom, Belgium, + 6 others
Sponsor: Shire Pharmaceutical Development Limited

View study

CompletedEUCTR 2010-018409-13

A Phase 3b, Multicenter, Double-Blind, Fixed-Dose, Parallel-Group, Three Week Placebo Controlled Trial Evaluating the Safety and Efficacy of Asenapine in Subjects With Bipolarity type 1 Experie...

Official study title

A Phase 3b, Multicenter, Double-Blind, Fixed-Dose, Parallel-Group, Three Week Placebo Controlled Trial Evaluating the Safety and Efficacy of Asenapine in Subjects With Bipolar 1 Disorder Experie...

Original registry wording; source language not specified.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria

BipolarityHistorical research record

Countries: Bulgaria
Sponsor: Schering-Plough Research Institute, a Division of Schering

View study

PreviousPage 569 of 2,274Next page Back to top

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.